Clinical Trial Update: Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 study of ATR-101 in adults with advanced Adrenocortical Carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• ATR-101

Snippet

Sponsor: Millendo Therapeutics, Inc. | Conditions: Adrenocortical Carcinoma, Adrenal Cancer | Phase 1 | Status: COMPLETED